rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2006-1-27
|
pubmed:abstractText |
Evaluation of dose-volume-time-related factors in 64 patients treated with high-dose-rate brachytherapy (HDR-BT) as a boost to external beam radiotherapy (EBRT) for localized prostate cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0167-8140
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-6
|
pubmed:meshHeading |
pubmed-meshheading:16271785-Aged,
pubmed-meshheading:16271785-Aged, 80 and over,
pubmed-meshheading:16271785-Brachytherapy,
pubmed-meshheading:16271785-Combined Modality Therapy,
pubmed-meshheading:16271785-Dose-Response Relationship, Radiation,
pubmed-meshheading:16271785-Follow-Up Studies,
pubmed-meshheading:16271785-Humans,
pubmed-meshheading:16271785-Iridium Radioisotopes,
pubmed-meshheading:16271785-Male,
pubmed-meshheading:16271785-Middle Aged,
pubmed-meshheading:16271785-Prostatic Neoplasms,
pubmed-meshheading:16271785-Questionnaires,
pubmed-meshheading:16271785-Radiation Injuries,
pubmed-meshheading:16271785-Radiotherapy Dosage,
pubmed-meshheading:16271785-Rectum,
pubmed-meshheading:16271785-Urethra
|
pubmed:year |
2006
|
pubmed:articleTitle |
Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
|
pubmed:affiliation |
Department of Radiation Oncology, RWTH Aachen University, Aachen, Germany. mpinkawa@ukaachen.de
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|